• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RTS,S 疟疾疫苗诱导产生多功能抗体,并在 1/2a 期临床试验中具有保护作用。

Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a Trial.

机构信息

Burnet Institute, Melbourne, Australia.

Department of Immunology and Pathology, Monash University, Melbourne, Australia.

出版信息

J Infect Dis. 2021 Oct 13;224(7):1128-1138. doi: 10.1093/infdis/jiaa144.

DOI:10.1093/infdis/jiaa144
PMID:32236404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8514181/
Abstract

BACKGROUND

RTS,S is the leading malaria vaccine candidate but only confers partial efficacy against malaria in children. RTS,S is based on the major Plasmodium falciparum sporozoite surface antigen, circumsporozoite protein (CSP). The induction of anti-CSP antibodies is important for protection; however, it is unclear how these protective antibodies function.

METHODS

We quantified the induction of functional anti-CSP antibody responses in healthy malaria-naive adults (N = 45) vaccinated with RTS,S/AS01. This included the ability to mediate effector functions via the fragment crystallizable (Fc) region, such as interacting with human complement proteins and Fcγ-receptors (FcγRs) that are expressed on immune cells, which promote various immunological functions.

RESULTS

Our major findings were (1) RTS,S-induced antibodies mediated Fc-dependent effector functions, (2) functional antibodies were generally highest after the second vaccine dose, (3) functional antibodies targeted multiple regions of CSP, (4) participants with higher levels of functional antibodies had a reduced probability of developing parasitemia following homologous challenge (P < .05), and (5) nonprotected subjects had higher levels of anti-CSP IgM.

CONCLUSIONS

Our data suggest a role for Fc-dependent antibody effector functions in RTS,S-induced immunity. Enhancing the induction of these functional activities may be a strategy to improve the protective efficacy of RTS,S or other malaria vaccines.

CLINICAL TRIALS REGISTRATION

NCT00075049.

摘要

背景

RTS,S 是领先的疟疾疫苗候选者,但仅对儿童疟疾提供部分疗效。RTS,S 基于主要的恶性疟原虫裂殖子表面抗原环子孢子蛋白(CSP)。诱导抗 CSP 抗体对于保护至关重要;然而,这些保护性抗体如何发挥作用尚不清楚。

方法

我们定量测定了 45 名健康无疟疾的成年参与者接种 RTS,S/AS01 后对功能性抗 CSP 抗体应答的诱导情况。这包括通过片段可结晶(Fc)区域介导效应功能的能力,例如与人补体蛋白相互作用以及表达在免疫细胞上的 Fcγ-受体(FcγRs),这些受体促进各种免疫功能。

结果

我们的主要发现是:(1)RTS,S 诱导的抗体介导 Fc 依赖性效应功能;(2)功能性抗体通常在第二剂疫苗后最高;(3)功能性抗体针对 CSP 的多个区域;(4)具有更高水平功能性抗体的参与者在同源性挑战后发生寄生虫血症的概率降低(P<.05);(5)未受保护的个体具有更高水平的抗 CSP IgM。

结论

我们的数据表明 Fc 依赖性抗体效应功能在 RTS,S 诱导的免疫中发挥作用。增强这些功能性活动的诱导可能是提高 RTS,S 或其他疟疾疫苗保护效力的一种策略。

临床试验注册

NCT00075049。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/c555fa824bae/jiaa144f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/139dc767f3a4/jiaa144f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/d606c1497c9a/jiaa144f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/20e84b9c039f/jiaa144f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/de132438be26/jiaa144f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/acbd0a7da762/jiaa144f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/c555fa824bae/jiaa144f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/139dc767f3a4/jiaa144f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/d606c1497c9a/jiaa144f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/20e84b9c039f/jiaa144f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/de132438be26/jiaa144f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/acbd0a7da762/jiaa144f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/808c/8514181/c555fa824bae/jiaa144f0006.jpg

相似文献

1
Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a Trial.RTS,S 疟疾疫苗诱导产生多功能抗体,并在 1/2a 期临床试验中具有保护作用。
J Infect Dis. 2021 Oct 13;224(7):1128-1138. doi: 10.1093/infdis/jiaa144.
2
Antibody mechanisms of protection against malaria in RTS,S-vaccinated children: a post-hoc serological analysis of phase 2 trial.RTS,S 疫苗接种儿童抗疟疾的抗体机制: 2 期试验的事后血清学分析。
Lancet Microbe. 2024 Oct;5(10):100898. doi: 10.1016/S2666-5247(24)00130-7. Epub 2024 Aug 7.
3
Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure.RTS,S 疟疾疫苗在儿童中诱导和衰减功能性补体结合抗体,并受到疟疾暴露的负面影响。
BMC Med. 2019 Feb 25;17(1):45. doi: 10.1186/s12916-019-1277-x.
4
The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity.由候选疟疾疫苗RTS,S/AS01诱导产生的抗体的生物学功能由其精细特异性决定。
Malar J. 2016 May 31;15:301. doi: 10.1186/s12936-016-1348-9.
5
A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.一种基于单克隆抗体的免疫测定法,用于检测针对恶性疟原虫环子孢子蛋白重复区域的抗体反应。
Malar J. 2016 Nov 8;15(1):543. doi: 10.1186/s12936-016-1596-8.
6
Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children.接种 RTS,S 疟疾疫苗后儿童功能性抗体的诱导、衰减及其决定因素。
BMC Med. 2022 Aug 25;20(1):289. doi: 10.1186/s12916-022-02466-2.
7
RTS,S/AS01 malaria vaccine induces IgA responses against CSP and vaccine-unrelated antigens in African children in the phase 3 trial.RTS,S/AS01 疟疾疫苗在 3 期临床试验中诱导非洲儿童针对 CSP 和与疫苗无关的抗原产生 IgA 应答。
Vaccine. 2021 Jan 22;39(4):687-698. doi: 10.1016/j.vaccine.2020.12.038. Epub 2020 Dec 25.
8
A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults.一项 IIa 期、随机、双盲、安全性、免疫原性和疗效试验,评估用 AS02 佐剂配制的恶性疟原虫裂殖子表面蛋白 1 和 RTS,S 疫苗抗原在健康、无疟疾的成年人中的效果。
Vaccine. 2024 Apr 30;42(12):3066-3074. doi: 10.1016/j.vaccine.2024.03.072. Epub 2024 Apr 6.
9
Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children.基线暴露、抗体亚类和乙型肝炎反应对 RTS,S/AS01E 疫苗接种后非洲儿童疟疾保护免疫的影响不同。
BMC Med. 2018 Oct 31;16(1):197. doi: 10.1186/s12916-018-1186-4.
10
Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children.肯尼亚儿童中 RTS,S/AS01 诱导的抗 CSP 抗体的 7 年动力学。
Malar J. 2021 Dec 2;20(1):452. doi: 10.1186/s12936-021-03961-2.

引用本文的文献

1
R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.R21/Matrix-M疟疾疫苗在既往接触过疟疾的成年人中引发多种免疫反应:来自一项IIb期人类疟疾感染对照试验的见解
Front Immunol. 2025 Jul 7;16:1620365. doi: 10.3389/fimmu.2025.1620365. eCollection 2025.
2
Malaria: past, present, and future.疟疾:过去、现在与未来。
Signal Transduct Target Ther. 2025 Jun 17;10(1):188. doi: 10.1038/s41392-025-02246-3.
3
Role of malaria exposure and off-target responses on RTS,S/AS02 vaccine immunogenicity and protection in Mozambican children.

本文引用的文献

1
IgM in human immunity to malaria.人对疟疾的免疫中的 IgM。
Sci Adv. 2019 Sep 25;5(9):eaax4489. doi: 10.1126/sciadv.aax4489. eCollection 2019 Sep.
2
Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy.抗体针对不同环子孢子蛋白表位的浓度和亲和力与 RTS,S/AS01E 疟疾疫苗的功效相关。
Nat Commun. 2019 May 15;10(1):2174. doi: 10.1038/s41467-019-10195-z.
3
Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure.
疟疾暴露和非靶向反应对莫桑比克儿童RTS,S/AS02疫苗免疫原性及保护作用的影响
NPJ Vaccines. 2025 Jun 6;10(1):116. doi: 10.1038/s41541-025-01167-0.
4
The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01.对疟疾疫苗RTS,S/AS01重复季节性加强剂量的抗环子孢子体抗体反应。
NPJ Vaccines. 2025 Feb 6;10(1):26. doi: 10.1038/s41541-025-01078-0.
5
Natural killer cell antibody-dependent cellular cytotoxicity to is impacted by cellular phenotypes, erythrocyte polymorphisms, parasite diversity and intensity of transmission.自然杀伤细胞对[具体对象未明确]的抗体依赖性细胞毒性受细胞表型、红细胞多态性、寄生虫多样性和传播强度的影响。
Clin Transl Immunology. 2024 Nov 1;13(11):e70005. doi: 10.1002/cti2.70005. eCollection 2024.
6
A systems serology approach to identifying key antibody correlates of protection from cerebral malaria in Malawian children.一种系统血清学方法,用于鉴定马拉维儿童中抗大脑疟疾的关键抗体保护相关性。
BMC Med. 2024 Sep 12;22(1):388. doi: 10.1186/s12916-024-03604-8.
7
Multistage protective anti-CelTOS monoclonal antibodies with cross-species sterile protection against malaria.多阶段保护型抗 CelTOS 单克隆抗体,对疟疾具有跨物种的无菌保护作用。
Nat Commun. 2024 Aug 29;15(1):7487. doi: 10.1038/s41467-024-51701-2.
8
The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria.疟原虫驱动的免疫调节网络对疟疾免疫的影响。
Nat Rev Immunol. 2024 Sep;24(9):637-653. doi: 10.1038/s41577-024-01041-5. Epub 2024 Jun 11.
9
Previous Malaria Exposures and Immune Dysregulation: Developing Strategies To Improve Malaria Vaccine Efficacy in Young Children.既往疟疾暴露与免疫失调:改善儿童疟疾疫苗效力的策略研究
Am J Trop Med Hyg. 2024 Mar 5;110(4):627-630. doi: 10.4269/ajtmh.23-0696. Print 2024 Apr 3.
10
A perspective on Oxford's R21/Matrix-M™ malaria vaccine and the future of global eradication efforts.对牛津大学的 R21/Matrix-M™ 疟疾疫苗的展望及对全球消除疟疾努力的未来的看法。
Malar J. 2024 Jan 12;23(1):16. doi: 10.1186/s12936-024-04846-w.
RTS,S 疟疾疫苗在儿童中诱导和衰减功能性补体结合抗体,并受到疟疾暴露的负面影响。
BMC Med. 2019 Feb 25;17(1):45. doi: 10.1186/s12916-019-1277-x.
4
Targets of complement-fixing antibodies in protective immunity against malaria in children.儿童疟疾保护性免疫中补体固定抗体的靶标。
Nat Commun. 2019 Feb 5;10(1):610. doi: 10.1038/s41467-019-08528-z.
5
Challenges and strategies for developing efficacious and long-lasting malaria vaccines.开发有效和持久的疟疾疫苗面临的挑战和策略。
Sci Transl Med. 2019 Jan 9;11(474). doi: 10.1126/scitranslmed.aau1458.
6
Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children.基线暴露、抗体亚类和乙型肝炎反应对 RTS,S/AS01E 疫苗接种后非洲儿童疟疾保护免疫的影响不同。
BMC Med. 2018 Oct 31;16(1):197. doi: 10.1186/s12916-018-1186-4.
7
The Complement System Contributes to Functional Antibody-Mediated Responses Induced by Immunization with Plasmodium falciparum Malaria Sporozoites.补体系统有助于诱导对疟原虫疟原虫孢子的免疫接种产生功能性抗体介导的反应。
Infect Immun. 2018 Jun 21;86(7). doi: 10.1128/IAI.00920-17. Print 2018 Jul.
8
Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children.人体抗体可激活补体针对疟原虫孢子,与儿童疟疾保护有关。
BMC Med. 2018 Apr 30;16(1):61. doi: 10.1186/s12916-018-1054-2.
9
Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial.在非洲儿童中,RTS,S/AS01 疟疾疫苗对乙肝抗原的免疫应答,以及与肺炎球菌结合疫苗和轮状病毒疫苗联合使用:一项随机对照试验。
Hum Vaccin Immunother. 2018 Jun 3;14(6):1489-1500. doi: 10.1080/21645515.2018.1442996. Epub 2018 Apr 13.
10
HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.与HIV精英控制相关的HIV-1包膜蛋白和Vpu特异性抗体依赖性细胞毒性反应。
J Virol. 2017 Aug 24;91(18). doi: 10.1128/JVI.00700-17. Print 2017 Sep 15.